Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers.
QMRO Home
Barts Cancer Institute
Centre for Haemato-Oncology
A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers.
QMRO Home
Barts Cancer Institute
Centre for Haemato-Oncology
A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers.
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers.
View/
Open
Accepted version (14.83Kb)
Volume
33
DOI
10.1200/jco.2015.33.15_suppl.2547
Issue
15
ISSN
0732-183X
Metadata
Show full item record
Authors
Blagden, SP; Rizzuto, I; Stavraka, C; O'Shea, D; Suppiah, P; Patel, M; Loyse, N; Sukumaran, A; Bharwani, N; Rockall, A
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/8343
Collections
Centre for Haemato-Oncology
[217]